First breast session at #ESMO26 highlights how China is developing novel drugs at rapid speed.

Dr Michelle Li· @michelle_li · X·2026-10-23 20:19· 2 days agoScore70

Body · original

Positive PFS results with HER2-directed ADCs (HORIZON-Breast06 + APEX-Breast01), but neither compare to current SoC of T-DXd.

Fights for market share, but does it push the needle?

272 views · 2 likes · 2 reposts · 0 replies

Conference abstracts

LBA13matched by Proffered paper 1: Breast cancer, early and advanced stage

Trastuzumab rezetecan (SHR-A1811) in HER2-low advanced breast cancer (BC): A randomized, phase 3 study (HORIZON-Breast06)

Source: Dr Michelle Li · x.com